These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3436573)

  • 1. [Transdermal estrogen substitution in the postmenopause].
    Fontana-Klaiber H; Koller J; Keller PJ
    Gynakol Rundsch; 1987; 27(4):225-33. PubMed ID: 3436573
    [No Abstract]   [Full Text] [Related]  

  • 2. [Patches: a new way for substitute estrogen therapy].
    Palacios S
    Med Clin (Barc); 1990 Sep; 95(9):336-7. PubMed ID: 2280618
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oral hormone therapy in pre- and postmenopause].
    Braendle W
    Med Klin (Munich); 1990 Apr; 85(4):200-5. PubMed ID: 2191210
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of disorders of the climacteric by vaginal, rectal and transdermal estrogen substitution].
    Lauritzen C
    Gynakologe; 1986 Dec; 19(4):248-53. PubMed ID: 3817597
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current view on the use of steroidal estrogens during menopause in women].
    Szymasiuk J; Sternadel Z; Bińkowska M
    Pol Tyg Lek; 1989 Dec 2-24; 44(49-52):965-9. PubMed ID: 2490302
    [No Abstract]   [Full Text] [Related]  

  • 6. Estrogen replacement therapy: an overview.
    Brenner PF
    Int J Fertil; 1986; 31(3 Suppl [ESTROGEN]):7-14. PubMed ID: 2906341
    [No Abstract]   [Full Text] [Related]  

  • 7. [Substitute estrogen treatment of women after the menopause from the internist's viewpoint].
    Chojnowska-Jezierska J
    Pol Tyg Lek; 1985 Jul; 40(30):852-4. PubMed ID: 3903698
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing postmenopausal osteoporosis with estrogen replacement therapy.
    Ettinger B
    Int J Fertil; 1986; 31(3 Suppl [ESTROGEN]):15-20. PubMed ID: 2906335
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness of transdermal administration of 17-beta-estradiol in the management of menopause].
    Grio R; Piacentino R; Abbondanza M; Cirnigliaro C; Fusi D; Corsello FP; Arrichiello G; Canestrelli M; Marchino GL
    Minerva Ginecol; 1992; 44(1-2):19-21. PubMed ID: 1508379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal estrogen.
    Med Lett Drugs Ther; 1986 Dec; 28(728):119-20. PubMed ID: 3784967
    [No Abstract]   [Full Text] [Related]  

  • 11. Types of estrogen and delivery systems.
    Whitehead MI
    Postgrad Med; 1989 Apr; Spec No():78-83; discussion 89-90. PubMed ID: 2542912
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormone substitution by injectable preparations and skin implants].
    Kuhl H
    Gynakologe; 1986 Dec; 19(4):241-7. PubMed ID: 3817596
    [No Abstract]   [Full Text] [Related]  

  • 13. [Only a few will gain from estrogen level determinations in connection to the follow-up of hormonal replacement therapy in menopause].
    Punnonen R
    Duodecim; 1999; 115(1):9-10. PubMed ID: 11830866
    [No Abstract]   [Full Text] [Related]  

  • 14. [Estrogen substitution using a transdermal system].
    Schenkel L; Barlier D; Gay C; Gschwind T
    Rev Fr Gynecol Obstet; 1988 Jun; 83(6):453-8. PubMed ID: 3043634
    [No Abstract]   [Full Text] [Related]  

  • 15. [Systen--transdermal estradiol for substitution following surgical menopause].
    Rachev E; Karag'ozov I
    Akush Ginekol (Sofiia); 1995; 34(3):74-6. PubMed ID: 8743861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of postmenopausal osteoporosis by estrogen/gestagen substitution therapy.
    Riis B; Christiansen C
    Med Klin (Munich); 1987 Mar; 82(6):238-41. PubMed ID: 3587168
    [No Abstract]   [Full Text] [Related]  

  • 17. [General undifferentiated estrogen (progestagen) substitution in the prevention of osteoporosis: contra].
    Ziegler R
    Med Klin (Munich); 1987 Mar; 82(6):241-4. PubMed ID: 3587169
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin sensitivity during postmenopausal hormone replacement with transdermal estradiol and intrauterine levonorgestrel.
    Raudaskoski T; Tomás C; Laatikainen T
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):540-5. PubMed ID: 10376866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
    Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
    Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.